chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Adverse reaction started at appx 2 am last night (after 5:30pm shot).   Woke up and had trouble falling back to sleep for 1-2 hrs.   Started feeling body aches in knees, legs, ankles.   Vax site on right arm was noticeably sore.    Had chills at 5:30 am when i woke up again (did not test for fever but was not sweating).   Fell back asleep until 8:30 and took 2 Advil and a 20 minute warm bath to help get rid of the chills.  Slept another hour and then got up for my normal breakfast.   Groggy all morning, but symptoms appear to be completed now at 11:45 am.     I had somewhat stronger  and longer adverse reaction after the 1st vacine on 3/21/21.   I believe the fatigue, body aches and chills lasted throughout the following day and evening.      I had 1 Negative Covid test in June last year but my son and some friends of his tested positive in appx June 2020 so it's quite possible i had asymptomatic covid at some point in the last year (which i understand from news stories my drive higher adverse reaction rates).
Woke up with sore, swollen throat and swollen upper lip; chest tightness, headache and general body aches.  She called in sick for that day's night shift.  No treatment.
Tiredness; discomfort in his arm for 2 days; arm soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 74 year-old male patient received bnt162b2 (BNT162B2), administration date 24Mar2021 (Lot number: ER8732) at the age of 74 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "armpit pain" (unspecified if ongoing); "tiredness" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Tiredness"; LIMB DISCOMFORT (non-serious), outcome "unknown", described as "discomfort in his arm for 2 days"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm soreness".   No follow-up attempts are possible. No further information is expected.
This case was reported by a nurse via sales rep and described the occurrence of heartbeats increased in a adult female patient who received SHINGRIX (batch number B9739, expiry date unknown) for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, several hours after receiving SHINGRIX, the patient experienced heartbeats increased, rash, weakness, joint pain and headache. On an unknown date, the outcome of the heartbeats increased, rash, weakness, joint pain and headache were unknown. The reporter considered the heartbeats increased, rash, weakness, joint pain and headache to be related to SHINGRIX. Additional details were provided as follow: The age at vaccination was not reported. Few hours after receiving SHINGRIX, the patient reported rash on back, shoulders and torso. The patient had weakness and her heart beat was rapidly increased. She also had joint aches and headache, reporteted by her. The nurse reported that, 2nd dose of SHINGRIX would not be administered and the adverse events were related to SHINGRIX.
Expired dose administered to patient/expiration date was on 07Nov2021/Expired vaccine dose administered to patient as their booster dose; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/expiration date was on 07Nov2021/Expired vaccine dose administered to patient as their booster dose) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A, 024m20A and 04220A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 10-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/expiration date was on 07Nov2021/Expired vaccine dose administered to patient as their booster dose). On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/expiration date was on 07Nov2021/Expired vaccine dose administered to patient as their booster dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medication reported.  the booster dose was administered after 30-day Use By Date or after manufacturer date of expiry. patient had reported that according to what she had written down, the expiration date was 17Nov2021 but when she scanned it, it said the expiration date was on 07Nov2021.   This case was linked to MOD21-163166 (Patient Link).
Pain at injection site on day of shot, next day chills and achy which continued throughout the next day.
I received the second shot of Shingrix 2 months after the first shot. After 3 days muscles in arms and legs were paralyzed. Had a hard time lifting myself from bed or the floor. Saw a physician who prescribed me 3 days of steroids. It is now September 2022, though I have improved, I can still feel a lack of strength in my muscles (legs mainly). I saw in PI that Guillain Barre is a possible adverse reaction. I am a 57 years old female in good health.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/22/2021 pfizer,Lot#EK9231 2nd dose: 01/12/2021 Pfizer,Lot# EL3248 Diagnosed covid positive:06/30/2021 Exposure:Community Symptoms:Fever, cough, fatigue,muscle aches, chills,sore throat, nausea/vomiting,runny nose,headache,sinus congestion
Patient received Men B and PCV23 left arm. she also received Hep A right arm. the following day she developed pain, redness, of the site. she was seen at a local urgent care twice, 3/4/21 and 3/5/21 due to the symptoms and pain . it hurt to lift her hand. in addition on 3/5/21  AM she felt chilled and achy. she was treated as a local reaction to vaccine and sent home. due to ongoing redness and swelling of left arm at site of the vaccinations and distal to it. she was seen in the office on 3/8/21. the redness and swelling improved. an area of induration, tenderness, pink at the vaccine site. apps 4 s 4 1/2 cm. not warm. given the presentation, we treated her with oral keflex.  her allergist also rx prednisone   of note. as she is a nurse, she received the moderna vaccine from an outside facility on 1/15/2021 and 2/12/2021. both left arm and both Lot # 030L2OA. Patient informed us she also received allergy shots in both arms on 2/18/2021. with local redness, swelling and itching.
Body ache, chills, low-grade fever, headache  Treated with Advil
HEART ATTACK REPORTED BY RELATIVE OF PATIENT. PATIENT IN HOSPITAL AS OF YESTERDAY 03/21/2021
Baseball sized red spot formed where I received my flu shot, upper left arm. It is slightly swollen and warm to touch. There is mild ache when touched. No other symptoms.
Rash in shape of the number 8. Slightly itchy. Fading and not itchy the next day.
63 yr old male, pt of Provider Not in System with PMH of COPD, HLD, PUD, HTN, Chronic pain, GERD, presented with diarrhea, found to have covid and colitis.   Covid-19 Virus Infection Date of onset of symptoms: 12/7 Symptoms present on admission: diarrhea, cough, SOB, fever Date of covid positive test: 12/9 Vaccination status: vaccinated Imaging: CXR with perihilar bronchitis, CT with enteritis Oxygen requirements on admission: None Current oxygen requirements: none Medical therapy: rocephin, doxycycline, paxlovid 12/9; abx now stopped Consultants following: ID Anticipated special isolation end date: 12/17 Continues to have fevers, CRP and PCT normal   Colitis with sepsis PIA Tmax 102.7, WBC normal-- >3.3 (likely from covid) Lipase, LFT, LA normal; no stool for PCR  On rocephin and flagyl since 12/9; now stopped   Hyponatremia Na 126-- >135, from decreased po intake Giving gentle hydration and regular diet   Pancytopenia WBC 5.16-- >2.8 Hb 11.3-- >12.3 Plts 163-- >123 Acute change likely from infection F/U with PCP in 1 week for repeat labs   Low TSH Denies any symptoms; normal FT4   Hypomagnesemia Replacing   PAD Continued plavix, statin PAD Continued plavix, statin   Chronic pain Continued home percocet and gabapentin   B/L AVN of hips Seen on CT, will refer to ortho on discharge
Consumer answered yes when asked if they experienced any side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Consumer answered yes when asked if they experienced any side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Consumer answered yes when asked if they experienced any side effects). At the time of the report, VACCINATION COMPLICATION (Consumer answered yes when asked if they experienced any side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment information was reported. No Concomitant medications were reported.   This case was linked to MOD21-135558 (Patient Link).   Reporter did not allow further contact
This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient died from blood clot. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0. 20210514012-COVID-19 VACCINE AD26.COV2.S-Blood clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: BLOOD CLOT
5-10 minutes after injection ct presented to clinic with metallic taste in her mouth, "racing heart", and sob. Obtained ct bp first time 169/109 second time 158/88. Ct did not appear in distress. After taking BP ct stated that she was feeling better. She stated she was breathing fine and felt like her heart slowed down. Ct refused to follow up at ER or primary care.
Day 8 after covid Madera injection red hot swollen itchy arm/bronci spasms and coughing flem clear thick/ also tingling in face right side took benedryl felt better /day 16 same thing happend.
I was administered the incorrect volume of Moderna Covid-19 Vaccine on Thursday, February 11, 2021. This was the second dose shot, I received 0.3 mL instead of 0.5 mL. This is an incorrect dosing error.
having diarrhea every single day/loose stool once in a while/still experiencing diarrhea; soreness in her left arm for two to three days; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (having diarrhea every single day/loose stool once in a while/still experiencing diarrhea) and PAIN IN EXTREMITY (soreness in her left arm for two to three days) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002CIA) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2021, the patient experienced PAIN IN EXTREMITY (soreness in her left arm for two to three days). On 16-Jul-2021, the patient experienced DIARRHOEA (having diarrhea every single day/loose stool once in a while/still experiencing diarrhea). At the time of the report, DIARRHOEA (having diarrhea every single day/loose stool once in a while/still experiencing diarrhea) and PAIN IN EXTREMITY (soreness in her left arm for two to three days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient has not taken any medications for her side effects. No concomitant medication was provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Non-Significant Follow up: No new information.
R/arm sore after shot. Within 24 hrs, arm was red, hot, swollen to "twice it's normal size". Med provider ordered Benadryl & ice packs for 24 hrs, followed by heat which began on Monday. Above symptoms, resolving.
Extreme joint pain throughout. Started with knee pain, then went to fingers, toes, and elbows
I had shortness of breath, chest pain, and a racing heart.  This happened two times while surfing.  The first time was just shortness of breath and chest pain.  The second time was all three symptoms.  This happened in approx July.  I have been surfing multiple times since then, and have not had another episode.  I never went to the doctor at the time.
this is one of four pt to devel an inj site rxn characterized by pain, swelling, & redness following receipt of vax;pt recovered p/being treated w/DPH & a Celestone inj;
Swelling (9 x 10 cm) and redness at injection site. Tenderness and small central bullae. No fever on admission, benign wbc (5.6). Admitted and treated with intravenous clindamycin, ibuprofen prn and limb elevation.
suspected vaccination failure/had 5 episodes; have had 5 episodes, all different; all extremely painful; external breakout on my left arm; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had internal shingles around abdomen into and around back for over a year) and pain (had pain was unbearable and almost ended his/her life).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure/had 5 episodes ) (serious criteria GSK medically significant), shingles (Verbatim: have had 5 episodes, all different), shingles (Verbatim: external breakout on my left arm) and pain (Verbatim: all extremely painful).  The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved and the outcome of the shingles was resolved (duration 3 months) and the outcome of the pain was not reported.   It was unknown if the reporter considered the vaccination failure, shingles, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, shingles and pain to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK receipt date: 17-Sept-2023 The case was received from the patient via interactive digital media. The patient have had the shingles vaccine and upon receiving the second one, the patient immediately had an external breakout on his or her left arm. No more vaccines for him or her. The patient have had 5 episodes, all different but all extremely painful. This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
8.45 am Flu vaccine given.10.20 am client felt hot, upset stomach,nausea and diarrhea. 10.45 skin itchy.To Urgent Care Clinic. Apparent testing and notified she was allergic to chicken feathers. Given benadryl and Cortisone plus 3 day supply of same. Told by physician not to have flu shot again.
MEDI 0003824 is a serious spontaneous case from a physician involving erythema multiforme. The reporter causality is probably not related to FluMist vaccine. A physician reported that a 10 year old child developed a rash 2 weeks after receipt of FluMist. The rash included the palms and was reported to be erythema multiforme. However, no mucosal involvement was reported. The reporter did not think this was related to FluMist. The patients clinical outcome is unknown. No other information is available at the time of this report. Important medical Event (OMIC).
This spontaneous report as received from a medical assistant refers to a 8 year old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient was vaccinated with a dose of VARIVAX (Merck) lot # J006358, expiry 23-MAy-2015 ("VFC" stock) 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX (Merck) doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX (Merck) was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unspecified date. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Right after the injection my tongue felt fuzzy for while but it was gone the next day.  I have a large black and blue which is now turning yellow.  Today my where the injection was started itching and feels more and reddish. There are also reddish welts.
This case was reported by a nurse and described the occurrence of lower limb numbness in a 20 year old female patient who received hepatitis B vaccine recombinant (Engerix-B). On 02 November 2004, the patient received the first dose of Engerix-B in the left arm. At an unspecified period of time following the administration of Engerix-B, on 02 November 2004, the patient experienced lower limb numbness, tingling, chills, flushing, dizziness, malaise, and an injection site reaction characterized as soreness. The events resolved on an unspecified date in November 2004. The nurse considered the events to possible be related to vaccination with Engerix-B.
Left arm burns and aches.  Has not stopped even with icing and heat sine day after shot.  March 4 forward
After 7 minutes of the shot, the following events/symptoms started and gradually developed within 25 minutes:       Fast heart beat, change in eyesight and then a feeling of neck disappearing-non existent.     Episodes similar to Vasovagal (3)     Involuntary movement of arms and legs     Extremely cold hands, but I did not feel cold     Burning sensation inside the mouth     Numbness of mouth and lips, similar as when the dentist applies anesthesia     Mild Swelling of the mouth and tongue     Tightness and feeling of swollen throat and neck    Difficult to speak-speaking as in slow motion    Trouble swallowing    Trouble walking, legs weakness (continue in next paragraph) For approximately 45 minutes Healthcare personnel at the facility provided lots of fluids and assistance until there were neither episodes similar to Vasovagal nor involuntary movement of arms and legs, the hands had a normal temperature, some strength was regained, the symptoms remain mild (did not increase) and there were no new symptoms.        Hives in forehead, and  red blotches in right cheek, neck, chest      Hoarseness and feather sensation in throat After 2 hours of the shot, the hives and red blotches in the right cheek, neck, chest and the hoarseness and feather sensation in the throat developed.  The mouth, tongue and neck were still swollen and numb. At that time, 50mg of Benadryl were ingested, again at bedtime, and for the next 2 weeks.
W/I 24 hr. develop large area of redness, swelling, tenderness and warmth.
Had MMR4 varicella shots 5/20/13. On 5/29/2013 mother noted rash (non vesicular) at abdominal area slowly progressing to the trunk and extremities. No fever, no itchiness, no vomiting. No tenderness/pain. Positive decreased appetite because of lesion at throat. Advised fluids, BENADRYL and mouth wash (wash x1, BENADRYL).
It was reported that a female pt received a TD Adult vaccine on 8/31/99. Reportedly, within 24 hours, the pt experienced swelling from shoulder to hand which was also red, hot and painful.
Vaccinated in the left arm. PLUA 11AM 10/29/10 - 7pm on 10/31/10 left side of head, ear, neck pain. No rash. Pain to the touch. Reported to family doctor on Monday. Was prescribed VALTREX, helped with pain. Reported to pharmacy on 11/2/10 and was recovering.
tested for positive for COVID today; tested for positive for COVID today; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  A 52-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 52 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 29Sep2022, outcome "not recovered" and all described as "tested for positive for COVID today". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Sep2022) Positive, notes: just tested positive today, 29Sep on a home rapid test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that patient tested for positive for COVID today. Patient received the updated COVID Pfizer booster early September. Patient has had symptoms since Monday 26Sep202 but just tested positive today, 29Sep2022 on a home rapid test. His doctor prescribed Paxlovid.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Arm has itched at the vaccination site; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9263) via an unspecified route of administration in the left arm on 30Jan2021 at 13:15 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included rheumatoid arthritis. The patient was allergic to penicillin and demerol. Concomitant medications included EFFEXOR and centrum silver (MANUFACTURER UNKNOWN), TYLENOL, vitamin D (MANUFACTURER UNKNOWN) and Gingko biloba (MANUFACTURER UNKNOWN) for an unknown indication from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced  itch at the vaccination site since she had the first shot on 01Feb2021. The patient had her second shot on the other arm on an unspecified date. The patient did not received any treatment for the events. At the time of report, the clinical outcome of the event arm had itched at the vaccination site was not recovered. No follow-up attempts are needed. No further information is expected.